HuGE Literature Finder
Records
1
-
27
| Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer. Diagnostics (Basel, Switzerland) 2020 7 10 (7): . Otero-Estévez Olalla, Gallardo-Gomez María, Cadena María Páez de la, Rodríguez-Berrocal Francisco Javier, Cubiella Joaquín, Ramirez Vicent Hernandez, García-Nimo Laura, Chiara Loretta |
| Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers. Scientific reports 2019 7 9 (1): 10516. Tapial Sandra, Olmedillas-López Susana, Rueda Daniel, Arriba María, García Juan L, Vivas Alfredo, Pérez Jessica, Pena-Couso Laura, Olivera Rocío, Rodríguez Yolanda, García-Arranz Mariano, García-Olmo Damián, González-Sarmiento Rogelio, Urioste Miguel, Goel Ajay, Perea Jo |
| CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers. International journal of cancer 2017 09 141 (5): 967-976. Vedeld Hege Marie, Merok Marianne, Jeanmougin Marine, Danielsen Stine A, Honne Hilde, Presthus Gro Kummeneje, Svindland Aud, Sjo Ole H, Hektoen Merete, Eknaes Mette, Nesbakken Arild, Lothe Ragnhild A, Lind Guro |
| Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis. Oncotarget 2017 10 8 (37): 61917-61926. Tahara Tomomitsu, Hirata Ichiro, Nakano Naoko, Tahara Sayumi, Horiguchi Noriyuki, Kawamura Tomohiko, Okubo Masaaki, Ishizuka Takamitsu, Yamada Hyuga, Yoshida Dai, Ohmori Takafumi, Maeda Kohei, Komura Naruomi, Ikuno Hirokazu, Jodai Yasutaka, Kamano Toshiaki, Nagasaka Mitsuo, Nakagawa Yoshihito, Tuskamoto Tetsuya, Urano Makoto, Shibata Tomoyuki, Kuroda Makoto, Ohmiya Nao |
| Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer. British journal of cancer 2016 6 115 (2): 164-71. Cha Yongjun, Kim Kyung-Ju, Han Sae-Won, Rhee Ye Young, Bae Jeong Mo, Wen Xianyu, Cho Nam-Yun, Lee Dae-Won, Lee Kyung-Hun, Kim Tae-Yong, Oh Do-Youn, Im Seock-Ah, Bang Yung-Jue, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Kim Tae-Y |
| Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Clinical epigenetics 2015 7 7 (1): 63. Lee Dae-Won, Han Sae-Won, Cha Yongjun, Rhee Ye Young, Bae Jeong Mo, Cho Nam-Yun, Lee Kyung-Hun, Kim Tae-Yong, Oh Do-Youn, Im Seock-Ah, Bang Yung-Jue, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Kim Tae-Y |
| Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Clinical colorectal cancer 2015 12 15 (2): 164-9. Cohen Stacey A, Wu Chen, Yu Ming, Gourgioti Georgia, Wirtz Ralph, Raptou Georgia, Gkakou Chryssa, Kotoula Vassiliki, Pentheroudakis George, Papaxoinis George, Karavasilis Vasilios, Pectasides Dimitrios, Kalogeras Konstantine T, Fountzilas George, Grady William |
| Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer. International journal of clinical and experimental pathology 2015 5 8 (2): 1920-8. Kim Jung Ho, Cho Nam-Yun, Bae Jeong Mo, Kim Kyung-Ju, Rhee Ye-Young, Lee Hye Seung, Kang Gyeong Ho |
| Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer. BMC cancer 2014 4 14 245. Philipp Alexander B, Nagel Dorothea, Stieber Petra, Lamerz Rolf, Thalhammer Isabel, Herbst Andreas, Kolligs Frank |
| Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels. PloS one 2014 1 9 (1): e86657. Berg Marianne, Hagland Hanne R, Søreide Kjet |
| Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients. PloS one 2013 8 (3): 3. Shull AY, Clendenning ML, Ghoshal-Gupta S, Farrell CL, Vangapandu HV, Dudas L, Wilkerson BJ, Buckhaults PJ |
| Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. International journal of cancer 2012 10 132 (9): 2209-16. Han Sae-Won, Lee Hyun-Jung, Bae Jeong Mo, Cho Nam-Yun, Lee Kyung-Hun, Kim Tae-Yong, Oh Do-Youn, Im Seock-Ah, Bang Yung-Jue, Jeong Seung-Yong, Park Kyu Joo, Park Jae-Gahb, Kang Gyeong Hoon, Kim Tae-Y |
| Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer. Frontiers in oncology 2012 6 2 7. Zlobec Inti, Bihl Michel P, Foerster Anja, Rufle Alex, Terracciano Luigi, Lugli Alessand |
| B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PloS one 2011 6 (6): e21102. Schernhammer Eva S, Giovannucci Edward, Baba Yoshifumi, Fuchs Charles S, Ogino Shu |
| Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. The American journal of gastroenterology 2011 2 106 (6): 1110-8. Herbst Andreas, Rahmig Konstanze, Stieber Petra, Philipp Alexander, Jung Andreas, Ofner Andrea, Crispin Alexander, Neumann Jens, Lamerz Rolf, Kolligs Frank |
| Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer epidemiology 2010 Jun 34 (3): 338-44. Karpinski Pawel, Myszka Aleksander, Ramsey David, Misiak Blazej, Gil Justyna, Laczmanska Izabela, Grzebieniak Zygmunt, Sebzda Tadeusz, Smigiel Robert, Stembalska Agnieszka, Sasiadek Maria |
| 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology 2010 12 140 (4): 1174-81. Jover Rodrigo, Nguyen Thuy-Phuong, Pérez-Carbonell Lucía, Zapater Pedro, Payá Artemio, Alenda Cristina, Rojas Estefanía, Cubiella Joaquín, Balaguer Francesc, Morillas Juan D, Clofent Juan, Bujanda Luis, Reñé Josep M, Bessa Xavier, Xicola Rosa M, Nicolás-Pérez David, Castells Antoni, Andreu Montserrat, Llor Xavier, Boland C Richard, Goel Aj |
| PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 3 19 (3): 822-31. Baba Yoshifumi, Nosho Katsuhiko, Shima Kaori, Goessling Wolfram, Chan Andrew T, Ng Kimmie, Chan Jennifer A, Giovannucci Edward L, Fuchs Charles S, Ogino Shu |
| A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009 Nov 137 (5): 1609-20.e1-3. Nosho Katsuhiko, Kure Shoko, Irahara Natsumi, Shima Kaori, Baba Yoshifumi, Spiegelman Donna, Meyerhardt Jeffrey A, Giovannucci Edward L, Fuchs Charles S, Ogino Shu |
| Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Oct 18 (10): 2765-72. Kure Shoko, Nosho Katsuhiko, Baba Yoshifumi, Irahara Natsumi, Shima Kaori, Ng Kimmie, Meyerhardt Jeffrey A, Giovannucci Edward L, Fuchs Charles S, Ogino Shu |
| DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 2009 12 29 (11): 1653-62. Worthley D L, Whitehall V L J, Buttenshaw R L, Irahara N, Greco S A, Ramsnes I, Mallitt K-A, Le Leu R K, Winter J, Hu Y, Ogino S, Young G P, Leggett B |
| Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 10 15 (20): 6412-20. Ogino Shuji, Nosho Katsuhiko, Irahara Natsumi, Meyerhardt Jeffrey A, Baba Yoshifumi, Shima Kaori, Glickman Jonathan N, Ferrone Cristina R, Mino-Kenudson Mari, Tanaka Noriko, Dranoff Glenn, Giovannucci Edward L, Fuchs Charles |
| PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia (New York, N.Y.) 2008 Jun 10 (6): 534-41. Nosho Katsuhiko, Kawasaki Takako, Ohnishi Mutsuko, Suemoto Yuko, Kirkner Gregory J, Zepf Dimity, Yan Liying, Longtine Janina A, Fuchs Charles S, Ogino Shu |
| CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 1 21 (3): 245-55. Kawasaki Takako, Ohnishi Mutsuko, Nosho Katsuhiko, Suemoto Yuko, Kirkner Gregory J, Meyerhardt Jeffrey A, Fuchs Charles S, Ogino Shu |
| TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Human pathology 2007 Apr 38 (4): 614-20. Ogino Shuji, Kawasaki Takako, Ogawa Akiyo, Kirkner Gregory J, Loda Massimo, Fuchs Charles |
| CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Archiv : an international journal of pathology 2007 3 450 (5): 529-37. Ogino Shuji, Meyerhardt Jeffrey A, Kawasaki Takako, Clark Jeffrey W, Ryan David P, Kulke Matthew H, Enzinger Peter C, Wolpin Brian M, Loda Massimo, Fuchs Charles |
| CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006 1 55 (7): 1000-6. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner G J, Weisenberger D J, Campan M, Laird P W, Loda M, Fuchs C |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: